Rakovina Therapeutics Inc. RKV.V Stock
Rakovina Therapeutics Inc. Price Chart
Rakovina Therapeutics Inc. RKV.V Financial and Trading Overview
| Rakovina Therapeutics Inc. stock price | 0.09 CAD |
| Previous Close | 0.14 CAD |
| Open | 0.14 CAD |
| Bid | 0.13 CAD x N/A |
| Ask | 0.14 CAD x N/A |
| Day's Range | 0.14 - 0.14 CAD |
| 52 Week Range | 0.1 - 0.25 CAD |
| Volume | 5K CAD |
| Avg. Volume | 21.5K CAD |
| Market Cap | 9.43M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RKV.V Valuation Measures
| Enterprise Value | 9.43M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.5697675 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Rakovina Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -18.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.25 CAD |
| 52 Week Low | 0.1 CAD |
| 50-Day Moving Average | 0.14 CAD |
| 200-Day Moving Average | 0.16 CAD |
RKV.V Share Statistics
| Avg. Volume (3 month) | 21.5K CAD |
| Avg. Daily Volume (10-Days) | 14.6K CAD |
| Shares Outstanding | 69.83M |
| Float | N/A |
| Short Ratio | 0.02 |
| % Held by Insiders | 45.63% |
| % Held by Institutions | 0% |
| Shares Short | 700 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.086 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Rakovina Therapeutics Inc.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 1008 Beach Avenue |
| ZIP | V6E 1T7 |
| Phone | N/A |
| Website | https://www.rakovinatherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rakovina Therapeutics Inc. engages in the research and development of new cancer treatments based on novel series of small-molecule DNA-damage response inhibitors (DDRi). Its preclinical product pipeline include kt-2000, a next generation oral targeted small molecule PARP inhibitors; kt-3000, a bi-functional small-molecule drug candidate; and kt-4000, a DNA-damaging DDR inhibitors. Rakovina Therapeutics Inc. was formerly known as Vincero Capital Corp. The company is headquartered in Vancouver, Canada.
Q&A For Rakovina Therapeutics Inc. Stock
What is a current RKV.V stock price?
Rakovina Therapeutics Inc. RKV.V stock price today per share is 0.09 CAD.
How to purchase Rakovina Therapeutics Inc. stock?
You can buy RKV.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rakovina Therapeutics Inc.?
The stock symbol or ticker of Rakovina Therapeutics Inc. is RKV.V.
Which industry does the Rakovina Therapeutics Inc. company belong to?
The Rakovina Therapeutics Inc. industry is Biotechnology.
How many shares does Rakovina Therapeutics Inc. have in circulation?
The max supply of Rakovina Therapeutics Inc. shares is 69.83M.
What is Rakovina Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Rakovina Therapeutics Inc. PE Ratio is now.
What was Rakovina Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Rakovina Therapeutics Inc. EPS is -0.04 CAD over the trailing 12 months.
Which sector does the Rakovina Therapeutics Inc. company belong to?
The Rakovina Therapeutics Inc. sector is Healthcare.